Another study conducted by Fu et al. [40] also showed no significant association between TP53 rs1402522 polymorphism and Wilms tumor risk, and they found that CG/GG genotypes carriers significantly increased Wilms tumor risk in children younger than 18 months of age, compared with CC genotype carriers. Here, TP53 is linked to Nephroblastoma.